Trials / Recruiting
RecruitingNCT06772220
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This is a research study investigating elevated homocysteine in the blood of patients with Parkinson's disease who are currently receiving treatment with levodopa. We are evaluating if elevated homocysteine can be corrected using open label B vitamin therapy, as well as the impact of homocysteine levels on cognitive function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Folic Acid 1 MG | Folic Acid 1mg per day |
| DIETARY_SUPPLEMENT | Vitamin B6 25 MG | Vitamin B6, 25mg per day |
| DIETARY_SUPPLEMENT | Vitamin B12 | Vitamin B12, 1,000 ug per day |
Timeline
- Start date
- 2024-03-05
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2025-01-13
- Last updated
- 2025-01-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06772220. Inclusion in this directory is not an endorsement.